New York: The US Food and Drug Administration approved antiviral drug Remdisivir for treating the COVID-19 patients in the country.
The drug reportedly shortened the recovery time by 31 per cent or about four days for the patients admitted to the hospital.
Having manufactured by Gilead Sciences, a California based company, the FDA has allowed the use of the medication only during the pandemic.
Remdesivir, the antiviral drug was found to kill viruses like Ebola, Marburg, MERS and SARS. The medication disables virus RNA (ribonucleic acid) replication (through RNA, coronavirus replicates itself)
However, the drug failed the human trial stage for treating the Ebola virus in 2018-19.
Berhampur: Hundreds of thalassemia and sickle cell patients on Tuesday staged a demonstration demanding a…
Mumbai: Actress Samantha Ruth Prabhu and her ex-husband actor Naga Chaitanya have moved on after…
Mumbai: Amidst rumours of their divorce, Bollywood queen Aishwarya Rai asked women to stand up…
Bhubaneswar: Prime Minister Narendra Modi will participate in a roadshow on his arrival at Bhubaneswar…
New York: Elon Musk, father of 12 children with different partners, has led an eventful…
Bhubaneswar: Vigilance has apprehended a college principal while taking a bribe of Rs 1 lakh…
Mumbai: Ahead of the release of Allu Arjun's highly-anticipated ‘Pushpa: The Rule’, one of the…
Bhubaneswar: The Odisha government has rejected the application of IAS officer Sujata R Karthikeyan for…